Molecular Axiom

Developer of nucleic acid medicines to treat cancer and neurodegenerative diseases

placeSan Diego, California, United States calendar_todayFounded 2021 language molecularaxiom.com

Innovation

9 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 101 times.

YearFilings
20221
20232
20248
20258
20262

Investor mix

3 investors on record; lead investors include Oriental Fortune Capital.

Investor typeCountShare
Venture capital3100%
Coming soon